A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer

被引:35
作者
Tang, Ping [1 ,2 ]
Chen, Hui [3 ]
Uhlman, Matthew [4 ]
Lin, Yu-Rong [2 ]
Deng, Xiang-Rong [2 ]
Wang, Bin [2 ]
Yang, Wen-Jun [2 ]
Xie, Ke-Ji [2 ]
机构
[1] So Med Univ, Postgrad Inst, Guangzhou 510515, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Municipal Peoples Hosp 1, Dept Urol, Guangzhou 510180, Guangdong, Peoples R China
[3] Guangdong Prov Work Injury Rehabil Hosp, Dept Urol, Guangzhou 510440, Guangdong, Peoples R China
[4] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
基金
中国国家自然科学基金;
关键词
nomogram; prediction; prostate biopsy; prostate cancer; prostate-specific antigen (PSA); prostate volume (PV); age; digital rectal examination (DRE); BIOPSY OUTCOME PREDICTION; EXTERNAL VALIDATION; CALCULATOR; MORTALITY; MODELS; MEN;
D O I
10.1038/aja.2012.111
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Nomograms for predicting the risk of prostate cancer developed using other populations may introduce sizable bias when applied to a Chinese cohort. In the present study, we sought to develop a nomogram for predicting the probability of a positive initial prostate biopsy in a Chinese population. A total of 535 Chinese men who underwent a prostatic biopsy for the detection of prostate cancer in the past decade with complete biopsy data were included. Stepwise logistic regression was used to determine the independent predictors of a positive initial biopsy. Age, prostate-specific antigen (PSA), prostate volume (PV), digital rectal examination (DRE) status,% free PSA and transrectal ultrasound (TRUS) findings were included in the analysis. A nomogram model was developed that was based on these independent predictors to calculate the probability of a positive initial prostate biopsy. A receiver-operating characteristic curve was used to assess the accuracy of using the nomogram and PSA levels alone for predicting positive prostate biopsy. The rate for positive initial prostate biopsy was 41.7% (223/535). The independent variables used to predict a positive initial prostate biopsy were age, PSA, PV and DRE status. The areas under the receiver-operating characteristic curve for a positive initial prostate biopsy for PSA alone and the nomogram were 79.7% and 84.8%, respectively. Our results indicate that the risk of a positive initial prostate biopsy can be predicted to a satisfactory level in a Chinese population using our nomogram. The nomogram can be used to identify and counsel patients who should consider a prostate biopsy, ultimately enhancing accuracy in diagnosing prostate cancer. Asian Journal of Andrology (2013) 15, 129-133; doi:10.1038/aja.2012.111; published online 10 December 2012
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [21] Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
    Teoh, Jeremy Y. C.
    Yuen, Steffi K. K.
    Tsu, James H. L.
    Wong, Charles K. W.
    Ho, Brian S. H.
    Ng, Ada T. L.
    Ma, Wai-Kit
    Ho, Kwan-Lun
    Yiu, Ming-Kwong
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (05) : 821 - 825
  • [22] Prostate-specific antigen vaccines for prostate cancer
    Hörig, H
    Lee, CSD
    Kaufman, HL
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (04) : 395 - 408
  • [23] Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer
    Moon, DG
    Cheon, J
    Kim, JJ
    Yoon, DK
    Koh, SK
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (09) : 455 - 462
  • [24] Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3
    Perdona, Sisto
    Cavadas, Vitor
    Di Lorenzo, Giuseppe
    Damiano, Rocco
    Chiappetta, Gennaro
    Del Prete, Paola
    Franco, Renato
    Azzarito, Giuseppina
    Scala, Stefania
    Arra, Claudio
    De Sio, Marco
    Autorino, Riccardo
    [J]. EUROPEAN UROLOGY, 2011, 59 (01) : 81 - 87
  • [25] A multicenter study on the detection of prostate cancer by digital rectal examination and prostate-specific antigen in men with or without urinary symptoms
    Gil, MJ
    Allepuz, C
    Rioja, LA
    Servet, HM
    Filella, X
    Molina, R
    Ballesta, AM
    Tallada, M
    Cozar, JM
    delasNieves, HV
    Arruza, A
    Pertusa, C
    Cruces, H
    Flores, N
    Zubiaur, C
    Basurto, H
    Ballesteros, JJ
    Esperanza, H
    Jimenez, JF
    Sanz, S
    LaFe, H
    Gallego, J
    Mingol, VF
    Guajardo, J
    Alija, J
    deVilanova, HA
    Camacho, E
    Garcia, M
    Valme, H
    Saladie, JM
    Comet, J
    Pujol, HGTI
    Leiva, O
    Rodriguez, A
    Solsona, E
    Casanova, JL
    Concepcion, T
    Banares, F
    Chicharro, JA
    Burgos, R
    Gonzalez, M
    Gomez, F
    Canalejo, HJ
    Sebastian, JL
    Millan, JA
    delCamino, HV
    Carballido, J
    deHierro, HP
    Palazon, J
    Ortiz, B
    [J]. EUROPEAN UROLOGY, 1997, 32 (02) : 133 - 139
  • [26] Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
    Hansen, Jens
    Auprich, Marco
    Ahyai, Sascha A.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Stenzl, Arnulf
    Mulders, Peter F. A.
    Huland, Hartwig
    Fisch, Margit
    Abbou, Clement-Claude
    Schalken, Jack A.
    Fradet, Yves
    Marks, Leonard S.
    Ellis, William
    Partin, Alan W.
    Pummer, Karl
    Graefen, Markus
    Haese, Alexander
    Walz, Jochen
    Briganti, Alberto
    Shariat, Shahrokh F.
    Chun, Felix K.
    [J]. EUROPEAN UROLOGY, 2013, 63 (02) : 201 - 209
  • [27] Metastatic prostate cancer with a normal prostate-specific antigen level
    Ruiz-Martín I.
    Rodríguez-Sánchez C.A.
    Ocaña-Fernández A.
    Del Valle-Zapico J.
    De Prado-Otero D.S.
    Cruz-Hernández J.J.
    [J]. Clinical and Translational Oncology, 2005, 7 (9) : 412 - 413
  • [28] The role of an abnormal prostate-specific antigen level and an abnormal digital rectal examination in the diagnosis of prostate cancer: A cross-sectional study in Qatar
    Al Rumaihi, Khalid
    Al Jalham, Khalid
    Younes, Nagy
    Majzoub, Ahmad A.
    Shokeir, Ahmed A.
    [J]. ARAB JOURNAL OF UROLOGY, 2013, 11 (04) : 355 - 360
  • [29] Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity
    Okpua, Nelson C.
    Okekpa, Simon, I
    Njaka, Stanley
    Emeh, Augusta N.
    [J]. AFRICAN JOURNAL OF UROLOGY, 2021, 27 (01)
  • [30] Prostate-specific antigen-based prostate cancer screening: Past and future
    Alberts, Arnout R.
    Schoots, Ivo G.
    Roobol, Monique J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 524 - 532